
Yoon Jae Lee
Articles
-
Aug 8, 2024 |
nature.com | Beomjune Shin |Youngjin Kwon |Yoon Jae Lee |Jimin Lee |Woon-Hong Yeo
AbstractPreclinical studies are crucial for developing amyotrophic lateral sclerosis drugs. Current FDA-approved drugs have been created by monitoring limb muscle function and histological analysis of amyotrophic lateral sclerosis model animals. Drug candidates for this disease have yet to be tested for bulbar-onset type due to the limitations of traditional preclinical tools: excessive animal use and discrete detection of disease progress.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →